(Ebook) Malignant Liver Tumors: Current and Emerging Therapies, Third Edition by Pierre-Alain Clavien, Stefan Breitenstein, Jacques Belghiti, Ravi S. Chari, Josep M. Llovet, Chung-Mau Lo, Michael A. Morse, Tadatoshi Takayama, Jean-Nicolas Vauthey ISBN 9781405179768, 9781444317053, 1405179767, 1444317059

(Ebook) Malignant Liver Tumors: Current and Emerging Therapies, Third Edition by Pierre-Alain Clavien, Stefan Breitenstein, Jacques Belghiti, Ravi S. Chari, Josep M. Llovet, Chung-Mau Lo, Michael A. Morse, Tadatoshi Takayama, Jean-Nicolas Vauthey ISBN 9781405179768, 9781444317053, 1405179767, 1444317059

This comprehensive and critical review of current and established treatment modalities for malignant liver tumors is designed to help you sort through the proliferation of competitive approaches and choose the best treatment options for your patient. Dr. Clavien and his contributors consider all the options – radiological, surgical, pharmaceutical, and emerging/novel therapies – and help you find the best single or combined therapy. Building on the success of the previous edition, this extremely thorough revision: features a new section on Guidelines for Liver Tumors, where you will find specific strategies for treating common liver malignancies; the guidelines were prepared by the Associate Editors and take into account national and international society guidelines reflects actual practice by taking a multidisciplinary approach, with contributions from international experts who have extensive experience with this patient population achieves comprehensive and balanced coverage by having each chapter reviewed by the Editor, Deputy Editor, two Associate Editors, and at least one external reviewer includes 16 new chapters that cover liver anatomy, histologic changes in the liver, epidemiology and natural history of HCC, CCC and colorectal liver metastases, strategies of liver resection, and economic aspects as well as novel therapies facilitates the kind of daily interaction among hepatologists, hepatic surgeons, medical oncologists, radiotherapists, and interventional radiologists that is essential when treating patients with complex liver malignancies In 44 chapters organized into six major sections, the book covers the full range of liver tumors. The perfect blend of evidence and experience, Malignant Liver Tumors: Current and Emerging Therapies, 3rd Edition, illuminates the path to better patient care.Content: Chapter 1 From Promethean to Modern Times (pages 1–10): Kuno Lehmann, Stefan Breitenstein and Pierre?Alain ClavienChapter 2 Hepatic Anatomy and Terminology (pages 11–26): Steven M. StrasbergChapter 3 Histology and Pathology of Normal and Diseased Liver (pages 30–39): Valerie Paradis and Achim WeberChapter 4 Pathology of Primary and Secondary Malignant Liver Tumors (pages 40–51): Kay WashingtonChapter 5 Epidemiology, Etiology, and Natural History of Hepatocellular Carcinoma (pages 52–55): Wei?Chen Lee and Miin?Fu ChenChapter 6 Epidemiology, Etiology, and Natural History of Cholangiocarcinoma (pages 56–63): Peter Neuhaus, Ulf P. Neumann and Daniel SeehoferChapter 7 Epidemiology, Etiology, and Natural History of Colorectal Liver Metastases (pages 64–68): Robert J. PorteChapter 8 Tumor Markers in Primary and Secondary Liver Tumors (pages 69–75): Ketsia B. Pierre and Ravi S. ChariChapter 9 Modalities for Imaging Liver Tumors (pages 76–102): Dominik Weishaupt and Thomas F. HanyChapter 10 Systemic Treatment of Hepatobiliary Tumors (pages 107–121): Panagiotis Samaras, Michael A. Morse and Bernhard C. PestalozziChapter 11 External Beam Radiation Therapy for Liver Tumors (pages 122–130): Rakesh Reddy and A. Bapsi ChakravarthyChapter 12 Internal Radiation Therapy for Liver Tumors (pages 131–138): Ahsun Riaz, Laura Kulik, Michael Abecassis and Riad SalemChapter 13 Transarterial Embolization for Patients with Hepatocellular Carcinoma (pages 139–150): Jordi Bruix, Carmen Ayuso and Maria I. RealChapter 14 Selective Continuous Intra?Arterial Chemotherapy for Liver Tumors (pages 151–163): Fidel D. Huitzil?Melendez, Stefan Breitenstein and Nancy KemenyChapter 15 Isolated Hepatic Perfusion and Percutaneous Hepatic Perfusion (pages 164–172): Charles K. Heller, James F. Pingpank and Steven K. LibuttiChapter 16 Liver Resection of Primary Tumors: Hepatocellular Carcinoma, Cholangiocarcinoma, and Gallbladder Cancer (pages 177–191): Tadatoshi Takayama and Masatoshi MakuuchiChapter 17 Liver Resection of Colorectal Liver Metastases (pages 192–202): Daria Zorzi, Yun Shin Chun and Jean?Nicolas VautheyChapter 18 Laparoscopic Liver Resection (pages 203–215): Luca Vigano and Daniel CherquiChapter 19 Repeat Resection for Liver Tumors (pages 216–226): Mickael Lesurtel and Henrik PetrowskyChapter 20 Cryoablation of Liver Tumors (pages 227–243): Sivakumar Gananadha and David L. MorrisChapter 21 Thermal Ablation of Liver Tumors by Radiofrequency, Microwave, and Laser Therapy (pages 244–265): M. B. Majella Doyle and David C. LinehanChapter 22 Ethanol and Other Percutaneous Injection Modalities in the Treatment of Liver Tumors (pages 266–280): Michael A. Heneghan and Andrew D. YeomanChapter 23 Transplantation for Liver Tumors (pages 281–295): Francois Durand, Claire Francoz and Jacques BelghitiChapter 24 Preventing Recurrence of Hepatocellular Carcinoma after Curative Resection (pages 296–303): Stefan Breitenstein, Dimitris Dimitroulis and Beat MullhauptChapter 25 Strategies for Safer Liver Surgery (pages 308–316): Philipp Dutkowski, Olivier de Rougemont and Pierre?Alain ClavienChapter 26 Hepatocellular Carcinoma (pages 317–323): Tadatoshi TakayamaChapter 27 Cholangiocarcinoma (pages 324–332): Jacques Belghiti and Charles B. RosenChapter 28 Gallbladder Cancer (pages 333–341): Juan Hepp and Chung?Mau LoChapter 29 Colorectal Liver Metastases (pages 342–346): Phuong L. Doan, Jean?Nicolas Vauthey, Martin Palavecino and Michael A. MorseChapter 30 Viral?Based Therapies for Primary and Secondary Liver Cancer (pages 352–367): Menghua Dai, Lorena Gonzalez and Yuman FongChapter 31 Signaling Pathways and Rationale for Molecular Therapies in Hepatocellular Carcinoma (pages 368–381): Augusto Villanueva, Clara Alsinet and Josep M. LlovetChapter 32 Novel Therapies Targeted at Signal Transduction in Liver Tumors (pages 382–392): Fidel D. Huitzil?Melendez, Ghassan K. Abou?Alfa and Michael A. MorseChapter 33 Induction of Apoptosis in Liver Tumors (pages 393–399): Markus Selzner and Pierre?Alain ClavienChapter 34 Antiangiogenic Agents for Liver Tumors (pages 400–413): Mathijs Vogten, Emile E. Voest and Inne H. M. Borel RinkesChapter 35 Integrative Oncology: Alternative and Complementary Treatments (pages 414–420): Barrie R. Cassileth and Jyothirmai GubiliChapter 36 Liver Metastases from Endocrine Tumors (pages 424–438): Clayton D. Knox and C. Wright PinsonChapter 37 Uncommon Primary and Metastatic Liver Tumors (pages 439–453): Stefan Breitenstein, Ashraf Mohammad El?Badry and Pierre?Alain ClavienChapter 38 Liver Tumors in Special Populations (pages 454–474): Tadahiro Uemura, Akhtar Khan and Zakiyah KadryChapter 39 Malignant Liver Tumors in Children (pages 475–486): Xavier Rogiers and Ruth De BruyneChapter 40 Liver Tumors in Asia (pages 487–499): Norihiro Kokudo, Sumihito Tamura and Masatoshi MakuuchiChapter 41 Liver Tumors in South America (pages 500–508): Lucas McCormack and Eduardo de SantibanesChapter 42 Liver Tumors in Africa (pages 509–518): Michael C. KewChapter 43 Anesthetic Management of Liver Surgery (pages 519–530): Marco P. ZalunardoChapter 44 Qualitative and Economic Aspects of Liver Surgery (pages 531–538): Rene Vonlanthen, Ksenija Slankamenac and Christian Ernst